摘要:
Compositions and methods for modulating OB-cadherin-mediated functions are provided. The compositions and methods employ OB-cadherin modulating agents which generally comprise one or more of: (a) a peptide sequence that is at least 50% identical to an OB-cadherin CAR sequence; (b) a non-peptide mimetic of an OB-cadherin CAR sequence; (c) a substance, such as an antibody or antigen-binding fragment thereof, that specifically binds an OB-cadherin CAR sequence; and/or (d) a polynucleotide encoding a polypeptide that comprises an OB-cadherin CAR sequence or analogue thereof.
摘要:
Methods for diagnosing cancer, such as prostate, ovarian or breast cancer, as well as leukemia, are provided. Such methods may employ binding agents, such as antibodies or CAR sequences of OB-cadherin or N-cadherin, that specifically bind to OB-cadherin or N-cadherin, or polynucleotides that hybridize to a polynucleotide encoding OB-cadherin or N-cadherin. Also provided are methods for monitoring the progression of a cancer and to evaluate the metastatic potential of a cancer.
摘要:
A solid state thermal control device contains a substrate and a plurality of solid state thermal elements on the substrate. The thermal elements are adapted to provide thermal control to a device under test (DUT). Each solid state thermal element contains at least one solid state heater and an active control circuit adapted to control a thermal output of the heater. Optionally, the each thermal element may also include a solid state temperature sensor.
摘要:
A solid state thermal control device contains a substrate and a plurality of solid state thermal elements on the substrate. The thermal elements are adapted to provide thermal control to a device under test (DUT). Each solid state thermal element contains at least one solid state heater and an active control circuit adapted to control a thermal output of the heater. Optionally, the each thermal element may also include a solid state temperature sensor.
摘要:
A system for providing cable television comprises a cable provider providing television programming and a display to display the television programming, wherein the display receives the television programming via radio waves having a frequency at which cellular telephones operate.
摘要:
Agents for inhibiting cancer metastasis are provided. The methods comprise administering to a patient an antimetastatic agent that comprises one or more of: (a) a peptide sequence that is at least 50% identical to an OB-cadherin CAR sequence; (b) a non-peptide mimetic of an OB-cadherin CAR sequence; (c) a substance, such as an antibody or antigen-binding fragment thereof, that specifically binds an OB-cadherin CAR sequence; and/or (d) a polynucleotide encoding a polypeptide that comprises an OB-cadherin CAR sequence or analogue thereof.
摘要:
Modulating agents for inhibiting &bgr;-catenin mediated gene expression are provided. The modulating agents comprise one or more of: (1) the peptide sequence LXXLL (SEQ ID NO:1); or (2) a peptide analogue or peptidomimetic thereof. Methods for using such modulating agents for modulating &bgr;-catenin mediated gene expression and cellular differentiation in a variety of contexts (e.g., for modulating hair growth or treating cancer or Alzheimer's disease) are provided.
摘要翻译:提供了用于抑制β-连环蛋白介导的基因表达的调节剂。 调节剂包含以下一种或多种:(1)肽序列LXXLL(SEQ ID NO:1); 或(2)肽类似物或肽模拟物。 提供了使用这种调节剂调节各种情况下(例如用于调节毛发生长或治疗癌症或阿尔茨海默氏病)的β-连环蛋白介导的基因表达和细胞分化的方法。
摘要:
Compositions and methods for modulating VE-cadherin-mediated functions are provided. The compositions and methods employ VE-cadherin modulating agents which generally comprise one or more of: (a) a peptide sequence that is at least 50% identical to a VE-cadherin cell adhesion recognition sequence; (b) a non-peptide mimetic of a VE-cadherin cell adhesion recognition sequence; (c) a substance, such as an antibody or antigen-binding fragment thereof, that specifically binds a VE-cadherin cell adhesion recognition sequence; and/or (d) a polynucleotide encoding a polypeptide that comprises a VE-cadherin cell adhesion recognition sequence or analogue thereof.
摘要:
Modulating agents for inhibiting degradation of cytoplasmic &bgr;-catenin are provided. The modulating agents comprise one or more of: (1) the peptide sequence SYLDS(PO4)GIHS(PO4)G (SEQ ID NO:1) or (2) a peptide analogue or peptidomimetic thereof. Methods for using such modulating agents for stimulating &bgr;-catenin mediated gene expression and cellular differentiation are provided.
摘要翻译:提供了抑制细胞质β-连环蛋白降解的调节剂。 调节剂包括以下一种或多种:(1)肽序列SYLDS(PO4)GIHS(PO4)G(SEQ ID NO:1)或(2)肽类似物或肽模拟物。 提供了使用这种调节剂刺激β-连环蛋白介导的基因表达和细胞分化的方法。
摘要:
Modulating agents for inhibiting &bgr;-catenin mediated gene expression are provided. The modulating agents comprise one or more of: (1) the peptide sequence LXXLL (SEQ ID NO:1); or (2) a peptide analogue or peptidomimetic thereof. Methods for using such modulating agents for modulating &bgr;-catenin mediated gene expression and cellular differentiation in a variety of contexts (e.g., for modulating hair growth or treating cancer or Alzheimer's disease) are provided.
摘要翻译:提供了用于抑制β-连环蛋白介导的基因表达的调节剂。 调节剂包含以下一种或多种:(1)肽序列LXXLL(SEQ ID NO:1); 或(2)肽类似物或肽模拟物。 提供了使用这种调节剂调节各种情况下(例如用于调节毛发生长或治疗癌症或阿尔茨海默氏病)的β-连环蛋白介导的基因表达和细胞分化的方法。